Invention Grant
US09301717B2 Determining analyte concentrations in biological fluids with abnormal output detection
有权
确定具有异常输出检测的生物液体中的分析物浓度
- Patent Title: Determining analyte concentrations in biological fluids with abnormal output detection
- Patent Title (中): 确定具有异常输出检测的生物液体中的分析物浓度
-
Application No.: US13536310Application Date: 2012-06-28
-
Publication No.: US09301717B2Publication Date: 2016-04-05
- Inventor: Scott Carpenter , Christine D. Nelson , Huan-Ping Wu
- Applicant: Scott Carpenter , Christine D. Nelson , Huan-Ping Wu
- Applicant Address: CH Basel
- Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee: Ascensia Diabetes Care Holdings AG
- Current Assignee Address: CH Basel
- Agency: Nixon Peabody LLP
- Main IPC: G01N31/00
- IPC: G01N31/00 ; G01N33/48 ; G01N33/50 ; A61B5/145 ; G06F19/12 ; G06F19/00 ; G06F19/18 ; A61B5/1486 ; C12Q1/00 ; G01N27/327

Abstract:
A biosensor has an abnormal output detection system that determines whether an output signal from the redox reaction of an analyte has a normal or abnormal shape or configuration. The abnormal output detection system improves the accuracy and precision of the biosensor in determining whether an output signal has a shape or configuration that may not provide an accurate and/or precise analysis of a biological fluid. The biosensor generates an output signal in response to the redox reaction of the analyte. The biosensor normalizes the output signal and compares the normalized output signal with one or more control limits. The biosensor may generate an error signal when the normalized output signal is not within the control limits.
Public/Granted literature
- US20120271559A1 Determining Analyte Concentrations in Biological Fluids with Abnormal Output Detection Public/Granted day:2012-10-25
Information query